Featuring the video recorded proceedings of events held in conjunction with important scientific symposia, live webcasts and closed meetings featuring the perspectives of renowned clinical investigators, these videos provide an overview of important advances in the management of a number of solid tumors and hematologic cancers.
…
continue reading
1
HER2-Low and HER2-Ultralow Breast Cancer | Rounds with the Investigators: Compelling Teaching Cases Focused on the Management of HER2-Low and HER2-Ultralow Breast Cancer
1:31:29
1:31:29
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
1:31:29
Featuring perspectives from Dr Aditya Bardia, Prof Giuseppe Curigliano, Dr Hope S Rugo and Dr Antonio C Wolff, including the following topics: Introduction (0:00) Optimizing the Identification of HER2-Low and HER2-Ultralow Breast Cancer — Dr Wolff (2:28) Available Data with HER2-Targeted Therapy for HER2-Low and HER2-Ultralow Disease — Dr Bardia (2…
…
continue reading
1
Multiple Myeloma | What Clinicians Want to Know: Addressing Current Questions and Controversies in the Management of Multiple Myeloma
1:57:11
1:57:11
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
1:57:11
Featuring perspectives from Dr Sagar Lonial, Prof Philippe Moreau, Dr Robert Z Orlowski, Dr Noopur Raje and Dr Paul G Richardson, moderated by Dr Lonial, including the following topics: Introduction (0:00) Management of Newly Diagnosed Multiple Myeloma (MM) — Dr Orlowski (1:26) Integration of Novel Therapies into the Management of Relapsed/Refracto…
…
continue reading
1
Chronic Lymphocytic Leukemia | What Clinicians Want to Know: Addressing Current Questions and Controversies in the Management of Chronic Lymphocytic Leukemia
1:57:07
1:57:07
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
1:57:07
Featuring perspectives from Dr Farrukh T Awan, Dr Bita Fakhri, Dr Kerry A Rogers and Dr William G Wierda, moderated by Dr Jeff Sharman, including the following topics: Introduction (0:00) Optimizing First-Line Therapy for Chronic Lymphocytic Leukemia (CLL) — Jeff Sharman, MD (1:44) Emerging Role of Bruton Tyrosine Kinase (BTK) Inhibitors in Combina…
…
continue reading
1
Colorectal and Gastroesophageal Cancers | Cases from the Community: Integrating New Research Findings into Practice
49:11
49:11
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
49:11
Featuring perspectives from Dr Christopher Lieu, moderated by Dr Stephen “Fred” Divers CME information and select publicationsDr. Neil Love による
…
continue reading
1
Hepatobiliary Cancers | Cases from the Community: Integrating New Research Findings into Practice
55:50
55:50
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
55:50
Featuring perspectives from Dr Daneng Li, moderated by Dr Stephen “Fred” Divers CME information and select publicationsDr. Neil Love による
…
continue reading
1
Gynecologic Cancers | Cases from the Community: Integrating New Research Findings into Practice
46:42
46:42
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
46:42
Featuring perspectives from Dr Kathleen N Moore, moderated by Dr Stephen “Fred” Divers CME information and select publicationsDr. Neil Love による
…
continue reading
1
Myelofibrosis | Cases from the Community: Integrating New Research Findings into Practice
51:44
51:44
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
51:44
Featuring perspectives from Dr Stephen T Oh, moderated by Dr Stephen “Fred” Divers CME information and select publicationsDr. Neil Love による
…
continue reading
1
ER-Positive Metastatic Breast Cancer | 5-Minute Journal Club: Reviewing the Role of Oral SERDs in the Management of ER-Positive Metastatic Breast Cancer — Issue 2
11:59
11:59
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
11:59
Featuring an interview with Dr Seth Wander, including the following topics: Design of SERENA-6, a Phase III switching trial of camizestrant for ESR1-mutant breast cancer during first-line treatment Turner N et al. Design of SERENA-6, a phase III switching trial of camizestrant in ESR1-mutant breast cancer during first-line treatment. Future Oncol 2…
…
continue reading
1
Leukemia and Myelodysplastic Syndromes | Cases from the Community: Integrating New Research Findings into Practice
51:45
51:45
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
51:45
Featuring perspectives from Dr Harry Paul Erba, moderated by Dr Stephen “Fred” Divers CME information and select publicationsDr. Neil Love による
…
continue reading
1
Lung Cancer | Cases from the Community: Integrating New Research Findings into Practice
48:03
48:03
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
48:03
Featuring perspectives from Dr Edward B Garon, moderated by Dr Stephen “Fred” Divers CME information and select publicationsDr. Neil Love による
…
continue reading
1
Lung Cancer | Meet The Professor: Current and Future Use of Nontargeted Therapy for Metastatic Non-Small Cell Lung Cancer — A 2024 World Conference on Lung Cancer Review
58:47
58:47
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
58:47
Featuring perspectives from Dr Heather Wakelee, including the following topics: Introduction (0:00) Cases: A man in his late 50s with metastatic carcinoma of the lung, no actionable genomic alteration (AGA), PD-L1-negative, and a man in his early 60s with metastatic squamous cell carcinoma of the lung, PD-L1-negative — Brian P Mulherin, MD and Tara…
…
continue reading
1
Breast Cancer | Exploring the Current Management Paradigm for Patients with Metastatic Triple-Negative Breast Cancer
59:42
59:42
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
59:42
Featuring perspectives from Dr Priyanka Sharma and Dr Sara M Tolaney, including the following topics: Introduction: Metastatic Triple-Negative Breast Cancer (mTNBC) — The Patient Perspective (0:00) Selection and Sequencing of Antibody-Drug Conjugates (5:09) Dosing and Tolerability of Sacituzumab Govitecan; Use of Anthracyclines (14:39) Case: A woma…
…
continue reading
1
Paroxysmal Nocturnal Hemoglobinuria | Practical Perspectives: Investigators Discuss the Current Management of Paroxysmal Nocturnal Hemoglobinuria
1:46:18
1:46:18
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
1:46:18
Featuring perspectives from Dr Gloria Gerber, Dr Jamie Koprivnikar, Prof Alexander Röth and Dr Jamile M Shammo, including the following topics: Introduction: Paroxysmal Nocturnal Hemoglobinuria (PNH) and the General Medical Oncologist Diagnosis of and myths and misperceptions about PNH (0:00) Overview — Biology and Pathophysiology Role of complemen…
…
continue reading